These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27305454)

  • 1. Oxaliplatin Binding to Human Copper Chaperone Atox1 and Protein Dimerization.
    Belviso BD; Galliani A; Lasorsa A; Mirabelli V; Caliandro R; Arnesano F; Natile G
    Inorg Chem; 2016 Jul; 55(13):6563-73. PubMed ID: 27305454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes.
    Xi Z; Guo W; Tian C; Wang F; Liu Y
    Metallomics; 2014 Mar; 6(3):491-7. PubMed ID: 24469739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking.
    Palm-Espling ME; Andersson CD; Björn E; Linusson A; Wittung-Stafshede P
    PLoS One; 2013; 8(7):e70473. PubMed ID: 23936210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of classical platinum agents with the monomeric and dimeric Atox1 proteins: a molecular dynamics simulation study.
    Wang X; Li C; Wang Y; Chen G
    Int J Mol Sci; 2013 Dec; 15(1):75-99. PubMed ID: 24362578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum transfer from hCTR1 to Atox1 is dependent on the type of platinum complex.
    Wu X; Yuan S; Wang E; Tong Y; Ma G; Wei K; Liu Y
    Metallomics; 2017 May; 9(5):546-555. PubMed ID: 28383086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs.
    Lasorsa A; Nardella MI; Rosato A; Mirabelli V; Caliandro R; Caliandro R; Natile G; Arnesano F
    J Am Chem Soc; 2019 Jul; 141(30):12109-12120. PubMed ID: 31283225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione.
    Nardella MI; Rosato A; Belviso BD; Caliandro R; Natile G; Arnesano F
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox sulfur chemistry of the copper chaperone Atox1 is regulated by the enzyme glutaredoxin 1, the reduction potential of the glutathione couple GSSG/2GSH and the availability of Cu(I).
    Brose J; La Fontaine S; Wedd AG; Xiao Z
    Metallomics; 2014 Apr; 6(4):793-808. PubMed ID: 24522867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of Copper and Cisplatin to Atox1 Is Mediated by Glutathione through the Formation of Metal-Sulfur Clusters.
    Dolgova NV; Yu C; Cvitkovic JP; Hodak M; Nienaber KH; Summers KL; Cotelesage JJH; Bernholc J; Kaminski GA; Pickering IJ; George GN; Dmitriev OY
    Biochemistry; 2017 Jun; 56(24):3129-3141. PubMed ID: 28549213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification.
    Dolgova NV; Nokhrin S; Yu CH; George GN; Dmitriev OY
    Biochem J; 2013 Aug; 454(1):147-56. PubMed ID: 23751120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cisplatin and analogue Pt(en)Cl2 with the copper metallo-chaperone Atox1.
    Sze CM; Shi Z; Khairallah GN; Feketeová L; O'Hair RA; Xiao Z; Donnelly PS; Wedd AG
    Metallomics; 2013 Aug; 5(8):946-54. PubMed ID: 23778981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction of platinum anticancer drugs and drug derivatives with a copper transporting protein, Atox1.
    Palm-Espling ME; Wittung-Stafshede P
    Biochem Pharmacol; 2012 Apr; 83(7):874-81. PubMed ID: 22285228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro.
    Kahra D; Mondol T; Niemiec MS; Wittung-Stafshede P
    Protein Pept Lett; 2015; 22(6):532-8. PubMed ID: 25962064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of New Potential Interaction Partners for Human Cytoplasmic Copper Chaperone Atox1: Roles in Gene Regulation?
    Öhrvik H; Wittung-Stafshede P
    Int J Mol Sci; 2015 Jul; 16(8):16728-39. PubMed ID: 26213915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Structure of the Human Copper Chaperone ATOX1 Bound to Zinc Ion.
    Mangini V; Belviso BD; Nardella MI; Natile G; Arnesano F; Caliandro R
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural flexibility of the human copper chaperone Atox1: Insights from combined pulsed EPR studies and computations.
    Levy AR; Turgeman M; Gevorkyan-Aiapetov L; Ruthstein S
    Protein Sci; 2017 Aug; 26(8):1609-1618. PubMed ID: 28543811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1.
    Tian Y; Fang T; Yuan S; Zheng Y; Arnesano F; Natile G; Liu Y
    Metallomics; 2018 May; 10(5):745-750. PubMed ID: 29721562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T versus D in the MTCXXC motif of copper transport proteins plays a role in directional metal transport.
    Niemiec MS; Dingeldein AP; Wittung-Stafshede P
    J Biol Inorg Chem; 2014 Aug; 19(6):1037-47. PubMed ID: 24824562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of cisplatin bound to a human copper chaperone.
    Boal AK; Rosenzweig AC
    J Am Chem Soc; 2009 Oct; 131(40):14196-7. PubMed ID: 19807176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: a joint mass spectrometry and circular dichroism investigation.
    Marzo T; Scaletti F; Michelucci E; Gabbiani C; Pescitelli G; Messori L; Massai L
    Biometals; 2015 Dec; 28(6):1079-85. PubMed ID: 26453060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.